<DOC>
	<DOCNO>NCT01482520</DOCNO>
	<brief_summary>All Hepatocellular carcinoma Renal cell carcinoma patient receive molecular target therapy candidate study . No additional treatment intervention conduct except blood sampling limit one time . Blood sample ( 10 cc volume ) collect study participant provide write informed consent form . DNA extract peripheral blood sample use DNA isolation kit .</brief_summary>
	<brief_title>Genome-wide Association Study Predict Treatment Response Molecular Targeted Therapy Hepatocellular Carcinoma Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>All Hepatocellular carcinoma Renal cell carcinoma patient receive molecular target therapy candidate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>